Effect of Alzheimer disease genetic risk disclosure on dietary supplement use

American Journal of Clinical Nutrition

Volumn 91, Issue 5, 2010, Pages 1402-1407

  Vernarelli, Jacqueline A ^a   Roberts, J Scott ^b   Hiraki, Susan ^a   Chen, Clara A ^c   Cupples, L Adrienne ^c   Green, Robert C ^a,c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON4; ASCORBIC ACID; CURCUMIN; FISH OIL; FOLIC ACID; HERBACEOUS AGENT; MINERAL; UNCLASSIFIED DRUG;

ADULT; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; EDUCATIONAL STATUS; EXERCISE; FAMILY HISTORY; FEMALE; GENETIC ANALYSIS; GENETIC RISK; HEALTH BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT EDUCATION; RISK ASSESSMENT; RISK REDUCTION; TEA;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; DIETARY SUPPLEMENTS; EDUCATIONAL STATUS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; RANDOM ALLOCATION; RISK ASSESSMENT; RISK FACTORS;

EID: 77951953129     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.3945/ajcn.2009.28981     Document Type: Article

References (37)

1. Peshkin BN, DeMarco TA, Brogan BM, Lerman C, Isaacs C. BRCA1/2 testing: complex themes in result interpretation. J Clin Oncol 2001;19: 2555-2565
2. Yoon PW, Chen B, Faucett A, et al. Public health impact of genetic tests at the end of the 20th century. Genet Med 2001;3:405-410
3. Hunter DJ, Khoury MJ, Drazen JM. Letting the genome out of the bottle - will we get our wish? N Engl J Med 2008;358:105-107
4. Offit K. Genomic profiles for disease risk: predictive or premature? JAMA 2008;299:1353-1355
5. Hudson K, Javitt G, Burke W, Byers P. ASHG Statement* on direct-to-consumer genetic testing in the United States. Obstet Gynecol 2007; 110:1392-1395
6. US Government Accountability Office. Nutrigenetic testing: tests purchased from four web sites mislead consumers. Washington, DC: US Government Accountability Office, 2006.
7. Bent S. Herbal medicine in the United States: review of efficacy, safety, and regulation: grand rounds at University of California, San Francisco Medical Center. J Gen Intern Med 2008;23:854-859
8. DeKosky ST, Williamson JD, Fitzpatrick AL, et al. Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA 2008;300: 2253-2262
9. Brouwers N, Sleegers K, Van Broeckhoven C. Molecular genetics of Alzheimer's disease: an update. Ann Med 2008;40:562-583
10. Li Y, Grupe A. Genetics of late-onset Alzheimer's disease: progress and prospect. Pharmacogenomics 2007;8:1747-1755
11. Green RC, Relkin NR, Whitehouse PJ, et al. The REVEAL Study: developing cumulative risk profiles to provide susceptibility genotyping, risk assessment and counseling for Alzheimer disease. Program and abstracts of the NIH Conference: A Decade of ELSI Research; January 16-18, 2001; Bethesda, MD.
12. Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex and ethnicity on the association between apolipoprotein E genotype and Alzheimer's disease: A meta-analysis. JAMA 1997;278:1349-1356
13. Bloss CS, Delis DC, Salmon DP, Bondi MW. Decreased cognition in children with risk factors for Alzheimer's disease. Biol Psychiatry 2008; 64:904-906
14. Chao S, Roberts JS, Marteau TM, Silliman RA, Green RC. Health behavior changes after genetic risk assessment for Alzheimer's disease: the REVEAL Study. Alzheimer Dis Assoc Disord 2008;22:94-97
15. Green R, Relkin N, Whitehouse P, et al. Early results of the REVEAL Study: risk evaluation and education for Alzheimer's disease. Poster presented at the 13th Annual Meeting of the American Neuropsychiatric Association; March 10, 2002; La Jolla, CA. Neuropsychiatry Clin Neurosci 2002;14:99-101.
16. Roberts JS, Cupples LA, Relkin N, Whitehouse PJ, Green RC. Genetic risk assessment for adult children of people with Alzheimer's disease: the Risk Evaluation and Education for Alzheimer's Disease (REVEAL) Study. J Geriatr Psychiatry Neurol 2005;18:250-255
17. Green RC, Roberts JS, Cupples LA, et al. Disclosure of APOE genotype for risk of Alzheimer's disease. N Engl J Med 2009;361:245-254
18. Cupples LA, Farrer LA, Sadovnick AD, Relkin N, Whitehouse P, Green RC. Estimating risk curves for first-degree relatives of patients with Alzheimer's disease: the REVEAL Study. Genet Med 2004;6:192-196 (Pubitemid 39005858)
19. Christensen KD, Roberts JS, Royal CD, et al. Incorporating ethnicity into genetic risk assessment for Alzheimer disease: the REVEAL study experience. Genet Med 2008;10:207-214 (Pubitemid 351416818)
20. Lambert JC, Heath S, Even G, et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 2009;41:1094-1099
21. Roses AD. The medical and economic roles of pipeline pharmacogenetics: Alzheimer's disease as a model of efficacy and HLA-B(*)5701 as a model of safety. Neuropsychopharmacology 2009;34:6-17.
22. Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report 2008;12:1-23.
23. Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States, 2002. Adv Data 2004;343:1-19.
24. Nahin RL, Barnes PM, Stussman BJ, Bloom B. Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. Natl Health Stat Report 2009;18:1-14.
25. Timbo BB, Ross MP, McCarthy PV, Lin CT. Dietary supplements in a national survey: Prevalence of use and reports of adverse events. J Am Diet Assoc 2006;106:1966-1974
26. Trevena J, Reeder A. Perceptions of New Zealand adults about reducing their risk of getting cancer. N Z Med J 2007;120:U2630. (Pubitemid 350055805)
27. Alamian A, Rouleau I, Simard J, Dorval M. Use of dietary supplements among women at high risk of hereditary breast and ovarian cancer (HBOC) tested for cancer susceptibility. Nutr Cancer 2006;54:157-165 (Pubitemid 44316297)
28. Nichter M, Thompson JJ. For my wellness, not just my illness: North Americans' use of dietary supplements. Cult Med Psychiatry 2006;30: 175-222. (Pubitemid 44326867)
29. Goddard KA, Robitaille J, Dowling NF, et al. Health-related direct-to-consumer genetic tests: a public health assessment and analysis of practices related to Internet-based tests for risk of thrombosis. Public Health Genomics 2009;12:92-104.
30. van Marum RJ. Current and future therapy in Alzheimer's disease. Fundam Clin Pharmacol 2008;22:265-274 (Pubitemid 351712889)
31. Alzheimer's Association. Brain health: adopt a brain healthy diet. Maintain your brain. Updated 27 August 2009. Available from: http://www.alz.org/we-can-help-adopt-a-brain-healthy-diet.asp (cited 22 June 2009).
32. Marsh SA, Coombes JS. Vitamin E and alpha-lipoic acid supplementation increase bleeding tendency via an intrinsic coagulation pathway. Clin Appl Thromb Hemost 2006;12:169-173
33. Podmore ID, Griffiths HR, Herbert KE, Mistry N, Mistry P, Lunec J. Vitamin C exhibits pro-oxidant properties. Nature 1998;392:559.
34. Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005;142:37-46.
35. Solomon PR, Adams F, Silver A, Zimmer J, DeVeaux R. Ginkgo for memory enhancement: a randomized controlled trial. JAMA 2002;288: 835-840
36. Strassburg MA, Simon PA, Fielding JE. Developing a public health Web site: the Los Angeles County experience. J Public Health Manag Pract 2002;8:44-53.
37. Laurent MR, Vickers TJ. Seeking health information online: does Wikipedia matter? J Am Med Inform Assoc 2009;16:471 9.